An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel Disease

Affiliations

• ¹ Connecticut Children's Hartford, CT, USA.
• ² MassGeneral Hospital for Children Boston, MA, USA.
• ³ Former Division Deputy Director Gastroenterology and Inborn Errors Products US FDA, 2010-2017, Cherry Hill, NJ, USA.
• ⁴ Pediatric IBD Foundation Bloomfield Hills, MI, USA.